Strong progress on trial reporting in Austria and Germany but worsening gaps in Italy - new data

"The majority of unreported drug trial results in Europe are now concentrated within just four countries, highlighting the strong differences in regulatory quality between European Union member states, a new report shows.

National medicines regulators that proactively chase up missing clinical trial results with pharma companies and universities have succeeded in significantly boosting reporting rates. This includes regulators in Germany, Austria, Denmark and Belgium.

In contrast, the number of missing results has further grown in Italy and France. In Italy alone, an estimated 1,299 clinical trial results are now missing in violation of European transparency rules. ..."